KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $992.3 million.

  • Neogenomics' Non-Current Assets fell 557.2% to $992.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $992.3 million, marking a year-over-year decrease of 557.2%. This contributed to the annual value of $1.0 billion for FY2024, which is 390.98% down from last year.
  • Neogenomics' Non-Current Assets amounted to $992.3 million in Q3 2025, which was down 557.2% from $1.0 billion recorded in Q2 2025.
  • Neogenomics' Non-Current Assets' 5-year high stood at $1.2 billion during Q3 2021, with a 5-year trough of $551.7 million in Q1 2021.
  • In the last 5 years, Neogenomics' Non-Current Assets had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • Per our database at Business Quant, Neogenomics' Non-Current Assets skyrocketed by 12308.63% in 2021 and then tumbled by 557.2% in 2025.
  • Over the past 5 years, Neogenomics' Non-Current Assets (Quarter) stood at $1.2 billion in 2021, then dropped by 4.5% to $1.1 billion in 2022, then dropped by 4.44% to $1.1 billion in 2023, then dropped by 3.91% to $1.0 billion in 2024, then fell by 4.77% to $992.3 million in 2025.
  • Its last three reported values are $992.3 million in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.